ENCEPHALOPATHY FOLLOWING MAPHARSEN THERAPY
- 1 June 1943
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1908)
- Vol. 71 (6) , 836-843
- https://doi.org/10.1001/archinte.1943.00210060097007
Abstract
Although mapharsen has been widely adopted in the treatment of syphilis since 1934, reports of fatalities from toxic effects following its use are few. In 1933 Cole and others1reported the first case of death attributed to mapharsen; acute nephrosis was the primary cause of death. Two years later Simon and Iglauer2reported a case in which a patient had died of anuria after five injections of mapharsen. Shortly afterward Rein and Wise3added 2 more cases with fatal outcome. In 1 of these aplastic anemia had developed; in the other granulocytopenia. In 1941 Kirkham and Perlmutter4reported a case in which death was due to aplastic anemia following twenty injections of mapharsen. The first report of mapharsen therapy followed by involvement of the central nervous system appeared in 1939 from India. Rajam and Rao5described a case in which hemorrhagic encephalitis followed the useThis publication has 0 references indexed in Scilit: